A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
NCT07218029
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
815
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
BIOLOGICAL:
Sotatercept
Sponsor
Merck Sharp & Dohme LLC